Life ScienceCompany
Aspen Pharmacare M&A Summary
Aspen Pharmacare has acquired 4 companies. It has also divested 2 assets.
Aspen Pharmacare’s largest acquisition to date was in 2013, when it acquired GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands for $1.1B. It’s largest disclosed sale occurred in 2020, when it sold Aspen Pharmacare Holdings - Thrombosis Business to Viatris for $723M. Aspen Pharmacare has acquired in 3 countries. The Company’s most targeted sectors include life science (75%) and food (25%).
Aspen Pharmacare Business Overview
Where is Aspen Pharmacare headquartered?
Aspen Pharmacare is headquartered in Durban, South Africa.
What is Aspen Pharmacare’s revenue?
Aspen Pharmacare disclosed revenue of 40,709M ZAR for 2023 and 38,606M ZAR for 2022.
How many employees does Aspen Pharmacare have?
Aspen Pharmacare has 8,612 employees.
What sector is Aspen Pharmacare in?
Aspen Pharmacare is a life science company.
When was Aspen Pharmacare founded?
Aspen Pharmacare was founded in 1850.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity4
- M&A Sell Activity2
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 4